Loading...
OTCM
EVARF
Market cap2kUSD
Nov 03, Last price  
0.00USD
Name

Lombard Medical Inc

Chart & performance

D1W1MN
OTCM:EVARF chart
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
14.99%
Revenues
12m
-19.49%
15,114,00012,169,000
Net income
-31m
L-17.91%
-37,804,000-31,035,000
CFO
-27m
L-22.69%
-34,397,000-26,591,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United States, United Kingdom, Germany, Japan, and other international regions. Its leading offering, Aorfix, is an endovascular stent-graft specifically engineered to address abdominal aortic aneurysms (AAAs) where the aneurysm's neck exhibits significant angulation, up to 90 degrees. Other solutions include the Altura endovascular stent graft system, tailored for more conventional AAA anatomies. Furthermore, Lombard Medical provides sophisticated delivery mechanisms: the Aorflex system ensures precise deployment of Aorfix within the abdominal aorta, while the IntelliFlex LP system further enhances the accuracy and control during Aorfix placement and deployment. The firm distributes its products through both its proprietary sales force and a network of distributors, primarily targeting state- or government-operated hospitals. Established in 2000, Lombard Medical, Inc. maintains its corporate headquarters in Didcot, United Kingdom.

Key people

Non-Executive Independent Chairman of the Board · since 2013
William Kullback
Chief Financial Officer · since 2014
Peter Phillips
Chief Technology Officer · since 2011
Simon Hubbert
Chief Executive Officer, Director
Director · since 2015
Non-Executive Director · since 2015
Timothy John Haines
Independent Director · since 2011
Simon Neathercoat
Senior Independent Director · since 2007
Craig Rennie
Independent Director · since 2007
John Rush
Independent Director
IPO date
Apr 25, 2014
Employees
113
Domiciled in
GB
Incorporated in
KY
Legal address
C/O Codan Trust Company (Cayman) Limited
PO Box 2681
Cricket Square
Hutchins Drive
George Town KY1-1111
KY
Headquarters
4 Trident Park
Didcot, OXF OX11 7HJ
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT